Gastric Metaplasia and Helicobacter pylori Infection in Hemodialysis Patients

Figures & data

Table 1. Endoscopic evaluation in hemodialysis patients.

	Male (n = 247)	Female (n = 159)	Total (n = 406)	GM (n = 139)	Helicobacter pylori (n = 98)
Age (years)	44.4 ± 13.9	45.2 ± 12.9	44.7 ± 13.5
Chronic erosive gastritis	121	72	173 (42.6%)	64	52
Chronic superficial gastritis	58	48	106 (26.1%)	31	30
Chronic bile reflux gastritis	24	23	47 (11.6%)	11	6
Chronic atrophic gastritis	1	0	1 (0.2%)	1	0
Chronic duodenitis	45	24	69 (17.0%)	13	16
Gastric ulcer	14	8	22 (5.4%)	6	5
Duodenal ulcer	12	5	17 (4.2%)	6	7
Multiple ulcers	9	3	12 (3.0%)	4	9
Gastric cancer	2	0	2 (0.5%)	2	1

Note: GM, gastric metaplasia.

Table 2. GM and Helicobacter pylori infection in hemodialysis patients according to hemodialysis (HD) duration.

	Group 1 (n = 275)	Group 2 (n = 70)	Group 3 (n = 28)	Group 4 (n = 33)
Sex (male/female)	156/119	49/21	20/8	22/11
Age (years)	44.1 ± 13.4	45.7 ± 12.8	43.1 ± 15.2	43.5 ± 14.2
Age range (years)	10–81	29–78	23–77	12–74
Helicobacter pylori (positive/total)	65/275 (23.6%)	21/70 (30.0%)	12/28 (42.9%)	0/33 (0)
GM (positive/total)	84/275 (30.5%)	28/70 (40.0%)	14/28 (50.0%)	16/33 (48.5%)

Note: GM, gastric metaplasia.

Table 3. Different levels of the GM in hemodialysis patients according to hemodialysis (HD) duration.

	Group 1 (n = 84)	Group 2 (n = 28)	Group 3 (n = 14)	Group 4 (n = 16)	Total (n = 142)
Mild (positive)	66	19	10	10	105
Moderate (positive)	14	4	4	4	26
Extensive (positive)	4	5	0	2	11

Note: GM, gastric metaplasia.